Source: International Congress 2017 – Systemic and airway biomarkers
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
G. Scioscia (Lucera, FG, Italy). Periostin in exhaled breath condensate as a biomarker of different severe asthma phenotypes.. 1017

Member's Comments

No comment yet.

Related content which might interest you: Inflammatory markers in exhaled breath condensate of two COPD phenotypes Source: Eur Respir J 2005; 26: Suppl. 49, 260s Year: 2005 Prediction of CF exacerbations by FeNO and non-invasive inflammatory markers in exhaled breath condensate Source: Annual Congress 2008 - Cystic fibrosis: novel aspects of airway function and inflammation Year: 2008 Prediction of asthma exacerbations in children by FeNO and non-invasive inflammatory markers in exhaled breath condensate Source: Annual Congress 2008 - Assessment of inflammation, hyperresponsiveness and response to exercise in asthmatic children Year: 2008 The biomarkers of atopy in exhaled breath condensate in patients with bronchial asthma Source: Annual Congress 2010 - Biomarkers and Diagnosis of asthma and allergic respiratory diseases Year: 2010 Exhaled breath condensate biomarkers in COPD Source: Eur Respir J 2008; 32: 472-486 Year: 2008 Markers of airway diseases in exhaled breath condensate and their clinical value Source: School Course 2013 - Monitoring of asthma, COPD and other airway diseases Year: 2013 Identifying biomarkers of loss of control/exacerbations in asthma from exhaled breath Source: ERS Lung Science Conference 2016 Year: 2016 Cystenil-leukotrienes as markers of airway inflammation in exhaled breath condensate of asthmatic children Source: Eur Respir J 2002; 20: Suppl. 38, 412s Year: 2002 Exhaled breath condensate for evaluation of inflammation in COPD patients Source: Eur Respir J 2006; 28: Suppl. 50, 35s Year: 2006 Correlation between lung function and exhaled breath condensate biomarkers of inflammation in pulmonary diseases Source: Annual Congress 2009 - Lung function in adults and children Year: 2009 Nitrite concentration in exhaled breath condensate correlates with markers of lung overdistension in COPD Source: Eur Respir J 2004; 24: Suppl. 48, 317s Year: 2004 Exhaled breath condensate eicosanoids as markers of asthma severity Source: Annual Congress 2008 - Understanding the mechanisms and the impact of severe asthma Year: 2008 Better characterization of local inflammation in COPD: detection of new biomarkers in exhaled breath condensate Source: Eur Respir J 2006; 28: Suppl. 50, 747s Year: 2006 Metabonomics applied to exhaled breath condensate in childhood asthma Source: Eur Respir J 2006; 28: Suppl. 50, 123s Year: 2006 The clinical significance of growth factors measurement in exhaled breath condensates (EBC) among patients with interstitial lung diseases Source: Annual Congress 2010 - Biomarkers in diffuse parenchymal lung disease Year: 2010 Inflammatory cytokines in exhaled breath condensate (EBC) of exacerbated COPD patients Source: Annual Congress 2008 - Inflammatory biomarkers Year: 2008 Detection and variability of cytokine-levels in exhaled breath condensate (EBC) of patients with stable COPD Source: Eur Respir J 2003; 22: Suppl. 45, 438s Year: 2003